logo
  

Burberry Appoints Kate Ferry As CFO And Executive Director

Burberry Group plc (BRBY.L), on Wednesday, said it appointed Kate Ferry as Chief Financial Officer and Executive Director. Kate will become a member of Burberry's Board and Executive Committee, reporting to Chief Executive Officer Jonathan Akeroyd.

Kate, who will join Burberry by early September 2023 at the latest, will be responsible for Finance and Business Services functions.

Kate is currently Chief Financial Officer of McLaren Group where she has overseen financial strategy and investor relations and has supported the broader strategic development of the company over the past two years. Prior to McLaren, Kate was Group Chief Financial Officer of TalkTalk Telecom Group PLC from 2017 to 2021. She is also currently an independent non-executive director of Greggs plc.

The company noted that Kate will succeed Julie Brown, currently Burberry Chief Operating and Financial Officer. Julie will leave Burberry on 1 April 2023, as previously announced.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
RELATED NEWS
Follow RTT